Pruritic Rash and Oral Erosions During Nivolumab Treatment for Melanoma: Bullous pemphigoid

Tamazian S, Chu EY, Simpson CL

SKIN: The Journal of Cutaneous Medicine, 5(1), 80–82.

View PDF

A 76-year-old man with a history  of  stage  3  melanoma  treated  with nivolumab    presented    with    a    persistent eruption  of  intensely  pruritic  papules  on  the trunk  that  started  six  months  after  initiating immunotherapy.  He denied skin blistering. The patient also reported  recurrent  blood-filled  blisters  in  the  mouth  that  ruptured  to form  painful  erosions.  Physical examination revealed   scattered   erythematous   papules without vesiculation on the back (Figure 1A), excoriated papules on the chest (Figure 1B), and several shallow  erosions  of  the  buccal mucosa  (Figure  1C).  Immunohistochemical (IHC) staining  of  the  skin  biopsy  showed linear deposition of complement protein C3d along  the  dermal-epidermal  junction  (Figure 2) and enzyme-linked immunosorbent assay (ELISA)   revealed   anti-BP180   antibodies, confirming a diagnosis of bullous pemphigoid

SKIN: The Journal of Cutaneous Medicine, 5(1), 80–82.